// App-Quantinova.ai

: A PILOT NON-INFERIORITY RANDOMIZED CONTROLLED TRIAL TO ASSESS AUTOMATIC ADJUSTMENTS OF INSULIN DOSES FOR PATIENTS WITH TYPE 1 DIABETES ON MULTIPLE DAILY INJECTIONS THERAPY

Researchers

Presenter

  • El Fathi A

Principal Investigators

  • Palisaitis E

  • Von Oettingen J.E

  • Krishnamoorthy P

  • Kearney R.E

  • Legault L

  • Haidar A

Medical Centers

  • McGill University, Electrical and Computer Engineering, Montreal, Canada

  • McGill University, Pediatrics, Montreal, Canada

  • McGill University, Biomedical Engineering, Montreal, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 1 diabetes mellitus

Biomarkers

  • Hemoglobin A1c

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Non Inferiority

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A